(Q33993075)

30 July 2017

1 reference

title

Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future (English)

1 reference

30 July 2017

Federico Turkheimer

2

0 references

Eric O Aboagye

object named as

Eric Aboagye

series ordinal

3

1 reference

ORCID Public Data File 2021

author name string

Giampaolo Tomasi

series ordinal

1

1 reference

30 July 2017

publication date

1 April 2012

1 reference

Molecular Imaging and Biology

30 July 2017

published in

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

131-146

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

30 July 2017

1 reference

Positron emission tomography as an imaging biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Use of positron emission tomography in anticancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Recommendations on the use of 18F-FDG PET in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Standards for PET image acquisition and quantitative data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Monitoring tumor response to therapy with 18F-FLT PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

PET kinetic analysis--compartmental model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Positron emission tomography compartmental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Graphical analysis of PET data applied to reversible and irreversible tracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Measurement of the global lumped constant for 2-deoxy-2-[18F]fluoro-D-glucose in normal human brain using [15O]water and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging. A method with validation based on multiple methodologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Strategies to improve neuroreceptor parameter estimation by linear regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Spectral analysis of dynamic PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

How should we analyse FDG PET studies for monitoring tumour response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Reproducibility of tumor perfusion measurements using 15O-labeled water and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Reproducibility of tumor blood flow quantification with 15O-water PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Partial-volume effect in PET tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Nonparametric Residue Analysis of Dynamic PET Data With Application to Cerebral FDG Studies in Normals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Minimizing artifacts resulting from respiratory and cardiac motion by optimization of the transmission scan in cardiac PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Prediction of short-term survival in patients with advanced nonsmall cell lung cancer following chemotherapy based on 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Predictive oncology: a review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

FLT-PET imaging of radiation responses in murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11307-011-0514-2

Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma

21 January 2018

1 reference

12 December 2020

Dissecting cancer through mathematics: from the cell to the animal model

1 reference

12 December 2020

Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma

1 reference

12 December 2020

Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.

1 reference

12 December 2020

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

1 reference

12 December 2020

Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.

1 reference

12 December 2020

Impact of cell-proliferation-associated gene expression on 2-deoxy-2-[(18)f]fluoro-D-glucose (FDG) kinetics as measured by dynamic positron emission tomography (dPET) in colorectal tumors

1 reference

12 December 2020

Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology

1 reference

12 December 2020

Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis

1 reference

12 December 2020

Reproducibility of metabolic measurements in malignant tumors using FDG PET

1 reference

12 December 2020

Breast imaging with fluorine-18-FDG PET: quantitative image analysis

1 reference

12 December 2020

PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.

1 reference

12 December 2020

A graphical analysis method to estimate blood-to-tissue transfer constants for tracers with labeled metabolites.

1 reference

12 December 2020

Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies

1 reference

12 December 2020

Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer

1 reference

12 December 2020

Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.

1 reference

12 December 2020

Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study

1 reference

12 December 2020

Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.

1 reference

12 December 2020

Use of PET for monitoring cancer therapy and for predicting outcome

1 reference

12 December 2020

Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

1 reference

12 December 2020

Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis.

1 reference

12 December 2020

Reference and target region modeling of [11C]-(R)-PK11195 brain studies

1 reference

12 December 2020

Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas

1 reference

12 December 2020

Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling

1 reference

12 December 2020

A threshold method to improve standardized uptake value reproducibility

1 reference

12 December 2020

Pharmacokinetic Imaging of11C Ethanol with PET in Eight Patients with Hepatocellular Carcinomas Who Were Scheduled for Treatment with Percutaneous Ethanol Injection

1 reference

12 December 2020

Assessment of proliferation in vivo using 2-[(11)C]thymidine positron emission tomography in advanced intra-abdominal malignancies

1 reference

12 December 2020

Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.

1 reference

12 December 2020

Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies.

1 reference

12 December 2020

2-[C-11]thymidine imaging of malignant brain tumors.

1 reference

12 December 2020

Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics

1 reference

12 December 2020

18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.

1 reference

12 December 2020

A general method to correct PET data for tissue metabolites using a dual-scan approach.

1 reference

12 December 2020

Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.

1 reference

12 December 2020

Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.

1 reference

12 December 2020

Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods

1 reference

12 December 2020

Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies

1 reference

12 December 2020

A quality-control method for SPECT-based dosimetry in targeted radionuclide therapy

1 reference

12 December 2020

Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer

1 reference

12 December 2020

Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

1 reference

12 December 2020

Global-two-stage filtering of clinical PET parametric maps: application to [(11)C]-(R)-PK11195.

1 reference

12 December 2020

Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.

1 reference

12 December 2020

Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.

1 reference

12 December 2020

Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements

1 reference

12 December 2020

Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats.

1 reference

12 December 2020

Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions

1 reference

12 December 2020

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

12 December 2020

A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue

1 reference

12 December 2020

18F-FLT-PET for detection of rectal cancer

1 reference

12 December 2020

Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics

1 reference

12 December 2020

Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using68Ga-DOTATOC PET and comparison with18F-FDG PET

1 reference

12 December 2020

10.1007/S11307-011-0514-2

Identifiers

DOI

1 reference

30 July 2017

1 reference